David S. Morris, MD, FACS

Urology Associates, PC

Nashville, Tennessee

David S. Morris, MD, FACS, is President of Urology Associates, P.C., in Nashville, Tennessee, where he also serves as Co-Director of the Advanced Therapeutics Center and Clinical Research Department. His clinical interests include urologic oncology, with a particular focus on advanced prostate cancer, as well as robotic and laparoscopic surgery, endourology, stone disease, and reconstructive urology.

Dr. Morris graduated summa cum laude from Vanderbilt University and earned his medical degree from Vanderbilt University School of Medicine. He completed his urology residency at the University of Michigan in Ann Arbor, where his research focused on genetic and genomic predictors of aggressiveness in prostate and bladder cancers. He has authored and co-authored multiple scientific publications and has presented his research at regional and national meetings.

Since entering practice in 2008, Dr. Morris has been actively involved in expanding access to advanced therapies and clinical research in community urology. The Advanced Therapeutics Center works closely with Urology Associates’ research program to conduct phase 2 and phase 3 clinical trials, particularly in genitourinary oncology.

Dr. Morris is a Fellow of the American College of Surgeons and a member of the American Urological Association, American Association of Clinical Urologists, and Endourological Society. He has also served on the Large Urology Group Practice Association’s Education and Program Committees, co-chaired LUGPA Forward, and was elected to the LUGPA Board of Directors in 2023.